insomnia Flashcards

1
Q

What is the definition of GastroEsophageal Reflux Disease (GERD)?

A

Symptoms, or complications resulting from the reflux of gastric contents into the esophagus or beyond, into the oral cavity (including larynx) or lung.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the two categories of GERD?

A
  • Symptoms without erosions on endoscopy (nonerosive reflux disease)
  • Symptoms with erosions on endoscopy (erosive reflux disease)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are typical symptoms of GERD?

A
  • Heartburn (pyrosis)
  • Regurgitation
  • Acidic taste in mouth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are extraesophageal (atypical) symptoms of GERD?

A
  • Chronic cough
  • Asthma-like symptoms
  • Recurrent sore throat
  • Laryngitis/hoarseness
  • Noncardiac chest pain
  • Sinusitis/pneumonia/bronchitis/otitis media (less common)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are alarm symptoms of GERD?

A
  • Dysphagia (difficult swallowing)
  • Odynophagia (painful swallowing)
  • Bleeding
  • Weight loss
  • Choking
  • Chest pain
  • Epigastric mass
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are aggravating factors of GERD?

A
  • Recumbency position (gravity)
  • Elevated intra-abdominal pressure
  • Reduced gastric motility (e.g., gastroparesis)
  • Decreased lower esophageal sphincter (LES) tone (e.g., peppermint, caffeine, nicotine)
  • Direct mucosal irritation (e.g., irritating foods, bisphosphonates, NSAIDs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the long-term complications of GERD?

A
  • Esophageal erosion
  • Strictures/obstruction
  • Barrett esophagus (increased risk of esophageal carcinoma)
  • Reduced quality of life (QoL)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are non-pharmacological interventions for GERD?

A
  • Avoid aggravating foods/beverages
  • Reduce fat intake
  • Avoid eating 2–3 hours before bedtime
  • Remain upright for two hours after meals
  • Weight loss if overweight or obese
  • Reduce/discontinue nicotine for tobacco users
  • Elevate the head of the bed if nocturnal symptoms present
  • Avoid tight-fitting clothing
  • Avoid medications that may reduce LES pressure or cause irritation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the pharmacologic therapies for GERD?

A
  • Antacids (OTC)
  • Histamine-2 antagonists (H2As) (OTC/POM)
  • Proton pump inhibitors (PPIs) (OTC/POM)
  • Promotility agents (OTC/POM)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the initial treatment approach for GERD based on severity?

A
  • “Step-down” treatment: Starting with maximal therapy for patients with documented esophageal erosion.
  • “Step-up” treatment: Starting with lower-dose OTC products.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What symptoms characterize dyspepsia?

A
  • Epigastric pain/discomfort
  • Bloating
  • Early satiety
  • Symptoms often related to meals and may improve after eating
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the recommendations for managing dyspepsia?

A
  • Endoscopy for patients at risk for serious outcomes
  • Testing and eradicating H. pylori
  • Using PPIs, tricyclic antidepressants (if functional), prokinetic agents
  • Psychotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the defensive forces in the pathophysiology of Peptic Ulcer Diseases (PUDs)?

A
  • Bicarbonate
  • Mucus layer
  • Mucosal blood flow
  • Prostaglandins
  • Growth factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the aggressive forces in the pathophysiology of PUDs?

A
  • Helicobacter pylori
  • HCl acid
  • Pepsins
  • NSAIDs
  • Ischemia & Hypoxia
  • Smoking and alcohol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are common causes of duodenal and gastric ulcers?

A
  • Duodenal ulcer: H. pylori infection (95%), NSAIDs
  • Gastric ulcer: NSAIDs, low-dose aspirin, H. pylori infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the clinical signs and symptoms of a duodenal ulcer?

A
  • Epigastric pain, possibly worse at night
  • Pain occurs 1-3 hours after a meal and may be relieved by eating
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the clinical signs and symptoms of a gastric ulcer?

A
  • Epigastric pain, often made worse by eating
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the non-invasive tests for H. pylori infection?

A
  • Serologic tests
  • Urea breath test (UBT)
  • Stool antigen tests
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the treatment regimen for H. pylori–associated ulcers?

A

An anti-secretory agent (preferably PPI) + at least two antibiotics for 10-14 days, followed by 2-4 additional weeks of PPI.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are preventive strategies for NSAID-induced ulcers?

A
  • Test and treat for H. pylori before long-term NSAID therapy
  • Determine levels of GI-related risk
  • Determine CV risk
21
Q

What is the medical management of Ulcerative Colitis (UC)?

A
  • Treatment based on disease location and severity
  • Mildly active UC: Topical AS for ulcerative proctitis, Oral AS for extensive colitis
  • Systemic steroids for nonresponding cases
22
Q

What are the two forms of Inflammatory Bowel Diseases (IBDs)?

A
  • Ulcerative Colitis (UC)
  • Crohn’s disease (CD)
23
Q

What are common symptoms of IBD?

A
  • Fever
  • Abdominal pain
  • Diarrhea (may be bloody, watery, or mucopurulent)
  • Rectal bleeding
  • Weight loss
24
Q

What is the role of colonoscopy in IBD management?

A

To confirm the diagnosis and extent of disease.

25
Q

What tests indicate inflammation in IBD?

A
  • Elevated concentrations of fecal lactoferrin
  • Fecal calprotectin
26
Q

What defines extensive disease in Ulcerative Colitis (UC)?

A

Proximal to splenic flexure requires systemic/oral therapy

Extensive disease indicates a more severe form of UC that requires more aggressive treatment.

27
Q

What is the recommended treatment for mildly active UC affecting the rectum and left-sided colitis?

A

Topical AS for ulcerative proctitis and left-sided colitis, with oral AS being more effective

AS refers to aminosalicylates.

28
Q

What should be used for induction of remission in mildly active extensive colitis?

A

Oral AS

AS stands for aminosalicylates, which are anti-inflammatory medications.

29
Q

What is the treatment for intolerant or nonresponding patients with left-sided UC?

A

Oral budesonide or systemic steroids

Budesonide is a corticosteroid used to treat UC.

30
Q

What are the main treatment options for moderately to severely active UC?

A

Systemic steroids, anti-TNF, or other biologics

Anti-TNF agents include infliximab.

31
Q

What should be combined with Infliximab for induction of remission in moderately to severely active UC?

A

Thiopurine therapy

Thiopurines include medications like azathioprine.

32
Q

If anti-TNF therapy fails in UC treatment, what are the alternatives?

A

Vedolizumab, Tofacitinib, or Ustekinumab

These are other classes of biologics used in UC.

33
Q

What is the initial treatment for hospitalized patients with acute severe UC?

A

Methylprednisolone I.V

This is a corticosteroid administered intravenously.

34
Q

What should be done if there is no response after 3–5 days of IV treatment for acute severe UC?

A

Rescue therapy with infliximab or cyclosporine

This is a critical step to manage severe cases.

35
Q

What is the first-line treatment for induction of remission in mild-active Crohn’s disease?

A

Oral AS (mesalamine or sulfasalazine)

Mesalamine and sulfasalazine are both aminosalicylates.

36
Q

What is preferred for terminal ileal or ascending colonic disease in Crohn’s disease?

A

Oral Budesonide

Budesonide is a corticosteroid effective in localized Crohn’s disease.

37
Q

What should be administered if a patient with Crohn’s disease is not responding to oral AS?

A

Oral Metronidazole

This antibiotic is particularly effective for perianal or colonic disease.

38
Q

What are the preferred therapies for moderate-active Crohn’s disease?

A

Anti-TNFα agents in combination with thiopurines

Infliximab is an alternative first-line treatment.

39
Q

What should be administered for severe-active Crohn’s disease?

A

Intravenous corticosteroids

This is crucial for managing severe symptoms.

40
Q

What may be needed after 5–7 days in severe-active Crohn’s disease management?

A

Parenteral nutrition (TPN)

TPN is used when oral intake is not feasible.

41
Q

What is the role of long-term corticosteroid use in Crohn’s disease maintenance therapy?

A

No role for long-term use, but oral budesonide may be used for up to 3 months

Long-term steroid use can lead to significant side effects.

42
Q

What can be used after induction with corticosteroids or infliximab in Crohn’s disease?

A

Azathioprine/6-MP

Azathioprine is an immunosuppressant.

43
Q

What therapies may prevent recurrence after surgical resection in Crohn’s disease?

A

Azathioprine/6-MP or mesalamine

These medications help maintain remission post-surgery.

44
Q

What antibiotics are used for simple perianal fistulas in Crohn’s disease?

A

Metronidazole or ciprofloxacin

These antibiotics can help manage infections in fistulas.

45
Q

What is the recommended management for complex perianal fistulas?

A

Anti-TNF in combination with surgery

Surgical intervention is often necessary for complex cases.

46
Q

What adjunctive therapies should be used with caution in active IBD?

A

Loperamide, antispasmodics, cholestyramine

These can reduce motility and potentially worsen conditions like toxic megacolon.

47
Q

What is the best treatment regimen for a 35-year-old man with newly diagnosed mildly active UC affecting the descending colon?

A

Mesalamine enema rectally once daily

This treatment is appropriate for left-sided UC.

48
Q

What is the best therapeutic choice for a 25-year-old woman with moderately active Crohn disease?

A

Infliximab intravenously and azathioprine daily

This combination is effective for moderate cases of Crohn’s disease.